Drug research

CardiolRx

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Cannabidiol; Pharmaceutically produced Cannabidiol; Pharmaceutically produced cannabidiol

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Impact of CardiolRx on Myocardial Recovery in Patients With Acute MyocarditisNCT05180240	CRDL	Phase 2	Completed	2025-01-31Actual
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)NCT05494788	CRDL	Phase 2	Completed	2024-06-15Actual
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)NCT06708299	CRDL	Phase 3	Recruiting	2026-09-21Estimated

CRDLCompletedPrimary completion: 2025-01-31 · Actual

Trial details

CRDLCompletedPrimary completion: 2024-06-15 · Actual

Trial details

CRDLRecruitingPrimary completion: 2026-09-21 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.